ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 117 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,014 | -19.1% | 37,844 | +8.1% | 0.00% | -33.3% |
Q2 2023 | $1,253 | +47.9% | 35,000 | 0.0% | 0.00% | +50.0% |
Q1 2023 | $847 | -69.6% | 35,000 | -50.0% | 0.00% | -71.4% |
Q4 2022 | $2,786 | -99.9% | 70,000 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $2,303,000 | -15.5% | 70,000 | -12.6% | 0.01% | -12.5% |
Q2 2022 | $2,724,000 | -8.2% | 80,050 | +23.1% | 0.01% | +14.3% |
Q1 2022 | $2,966,000 | -10.7% | 65,050 | +30.0% | 0.01% | -12.5% |
Q4 2021 | $3,321,000 | +25.2% | 50,050 | +14.1% | 0.01% | +14.3% |
Q3 2021 | $2,653,000 | +10.1% | 43,850 | +46.9% | 0.01% | 0.0% |
Q2 2021 | $2,409,000 | +27.5% | 29,850 | 0.0% | 0.01% | +16.7% |
Q1 2021 | $1,890,000 | -34.0% | 29,850 | -19.0% | 0.01% | -45.5% |
Q4 2020 | $2,865,000 | +47.0% | 36,850 | -17.6% | 0.01% | +22.2% |
Q3 2020 | $1,949,000 | +76.1% | 44,700 | +16.4% | 0.01% | +50.0% |
Q2 2019 | $1,107,000 | -28.3% | 38,400 | -64.2% | 0.01% | -33.3% |
Q1 2019 | $1,544,000 | +36.9% | 107,200 | +13.8% | 0.01% | +28.6% |
Q4 2018 | $1,128,000 | -26.9% | 94,200 | -12.1% | 0.01% | -22.2% |
Q3 2018 | $1,544,000 | +40.2% | 107,200 | +26.1% | 0.01% | +28.6% |
Q2 2018 | $1,101,000 | – | 85,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |